[Verse 1] SPACE trial dropped the data, systematic reviews confirmed Modest gains in function, dose-dependent harm we learned Opioids for chronic pain ain't the silver caliber Patient selection critical, screen before you prescribe her Rule out active substance use disorder, untreated mental state Sleep apnea lurking, that sedation gonna complicate Set the goals on function, not the numerical score Can you walk the block, return to work, do what you did before Frame it as a trial, ninety days, defined endpoint clear Treatment agreement signed, expectations engineered [Chorus] SPACE, PDMP, UDT — that's the trinity Function over scores, that's the clinical dignity Fifty MME, watch the threshold creeping tall No escalation without benefit, document it all Bowel regimen at day one, tolerance don't apply to gut Screen for apnea, check the hormones, keep the protocol shut-tight [Verse 2] Morphine milligram equivalents, fifty is the yellow flag Ninety MME or higher, now the risk is off the map Don't escalate the dosage if the function ain't improved Ceiling principle embedded, gotta stay within the groove Pill counts random, urine drug test verify Prescription drug monitoring every single time you write Reassess at intervals, quarterly at the least Documenting benefit, risk, and every increase If the patient's not responding, taper down the load No reward for tolerance alone, that ain't a valid road [Chorus] SPACE, PDMP, UDT — that's the trinity Function over scores, that's the clinical dignity Fifty MME, watch the threshold creeping tall No escalation without benefit, document it all Bowel regimen at day one, tolerance don't apply to gut Screen for apnea, check the hormones, keep the protocol shut-tight [Bridge] Extended-release formulations, timing matters here Opioid-naïve patient? Methadone? Keep that far from near Never for acute pain, the guidelines hammered that Conversion calculations, pharmacokinetics exact Hypogonadism creeping in from long-term opioid press Testosterone tanking, libido in distress Nausea hits the first two weeks, antiemetics bridge Sedation from the steady state, check the CNS ridge Constipation permanent — bowel never adapts Senna and osmotic agents from the very first relapse [Verse 3] So you got a patient, sixty-two, degenerative spine Failed the PT, failed the NSAIDs, gabapentin down the line Now you're weighing opioid trial, document the rationale Baseline function scored and noted, buprenorphine if available Informed consent covers: addiction, falls, and overdose Naloxone prescribed alongside, every patient gets a dose Thirty-day supply to start, no long-acting right away Conversion to extended-release after stable on short-day Then reassess at thirty, sixty, ninety off the clock If function's flat and pain unchanged, it's time to walk the doc back
← 2 Acute Opioid Prescribing | 4 Opioid Rotation and Conversion →